about
Profile of farletuzumab and its potential in the treatment of solid tumors7-difluoromethoxyl-5,4'-di-n-octyl genistein inhibits ovarian cancer stem cell characteristics through the downregulation of FOXM1.Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors.Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options.Targeting signaling pathways in epithelial ovarian cancer.Cystatin B is a progression marker of human epithelial ovarian tumors mediated by the TGF-β signaling pathway.Genetic changes in nonepithelial ovarian cancer.The current state of pemetrexed in ovarian cancer.Treatment of ovarian cancer beyond chemotherapy: are we hitting the target?miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway.The Role of the Immune System in Ovarian Cancer and Implications on Therapy.Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer.
P2860
Q26750431-4B2A9586-E819-46D4-B69E-6291B7E79DC4Q33778490-D89B859C-7B6E-4F5A-AB42-5E821939468AQ35780797-283F0038-1B12-42B4-8611-3A3187E621A6Q36648394-432F41E7-8C07-4E37-83F6-E8D1FC846E0AQ36913614-6BBAFFE9-598D-48DE-8A74-CB2D9D427CDCQ37688671-22EE2174-7AEA-417E-AC87-0ECA40826520Q38123207-47AB844C-0F6C-4E42-8C4B-6E229E4372F4Q38125259-B9DF0639-D9C6-45CA-86C8-7F8486B86E66Q38248418-5A7FA041-D354-4978-9DA8-B24833077AA0Q38705370-CAB9BAF7-C9DA-4540-83CB-54A0EEB234BCQ38715211-E7DCB6F4-BDCB-4ED3-BC7A-880FF53B63F6Q38995020-1BC1F3A4-7D2B-4DBD-B915-BC27BEE08E73
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Role of farletuzumab in epithelial ovarian carcinoma.
@ast
Role of farletuzumab in epithelial ovarian carcinoma.
@en
type
label
Role of farletuzumab in epithelial ovarian carcinoma.
@ast
Role of farletuzumab in epithelial ovarian carcinoma.
@en
prefLabel
Role of farletuzumab in epithelial ovarian carcinoma.
@ast
Role of farletuzumab in epithelial ovarian carcinoma.
@en
P2860
P1476
Role of farletuzumab in epithelial ovarian carcinoma.
@en
P2093
Danijela Jelovac
Deborah K Armstrong
P2860
P304
P356
10.2174/138161212802002698
P577
2012-01-01T00:00:00Z